Canonical: https://ownershiptrace.com/13f/companies/2480

# Who owns Cogent Biosciences, Inc. (COGT)? Elite investor 13F holders

3 tracked elite investors reported holding Cogent Biosciences, Inc as of 2026-06-30, including D.E. Shaw, Renaissance Technologies LLC, Oaktree Capital Management. Who bought, trimmed or exited each quarter, with links to the original SEC 13F filings.

3 tracked investors currently reported holding · Latest report period: 2026-06-30 · Health Care · Pharmaceuticals, Biotechnology & Life Sciences

Cogent Biosciences, Inc., a clinical-stage biotechnology company, focuses on developing precision therapies for genetically defined diseases. Its lead product candidate includes bezuclastinib (CGT9486), a selective tyrosine kinase inhibitor in Phase 3 trial designed to target mutations within the KIT receptor tyrosine kinase, including KIT D816V mutation that drives systemic mastocytosis, as well…

## Reported holders and securities, including exits (up to 20)

| Investor | Security | Instrument | Report period | Filed | Value | Quantity | Units | Change | Source |
|  --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| [D.E. Shaw](https://ownershiptrace.com/13f/investors/98) | Cogent Biosciences Inc | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 35699937.00 USD | 922479.000000 | Shares | reduce | [Original filing](https://www.sec.gov/Archives/edgar/data/1009207/0001104659-26-097217-index.html) |
| [Renaissance Technologies LLC](https://ownershiptrace.com/13f/investors/63) | Cogent Biosciences Inc | SHARE | 2026-06-30 | 2026-08-13 00:00:00 | 38551702.00 USD | 996168.000000 | Shares | add | [Original filing](https://www.sec.gov/Archives/edgar/data/1037389/0001037389-26-000059-index.html) |
| [Oaktree Capital Management](https://ownershiptrace.com/13f/investors/44) | COGENT BIOSCIENCES INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 14758452.00 USD | 11890000.000000 | Principal | add | [Original filing](https://www.sec.gov/Archives/edgar/data/949509/0000949509-26-000005-index.html) |

Public disclosures can be delayed, incomplete, or amended. Report period describes a position date; transaction date describes a reported transaction; filed describes submission. A recent filing or page update does not establish a current holding. A dash means unavailable or not comparable, not zero.

This public summary shows the default reporting scope. Enable JavaScript for interactive filters, charts, and additional rows.

[How to read the data](https://ownershiptrace.com/docs#reading-the-data) · [Disclaimer](https://ownershiptrace.com/disclaimer)